Aktienkurs
79.40
Täglich Wechseln
0.75 0.95%
Monatlich
-1.67%
Jährlich
52.55%
Q2 Prognose
79.04




Lieferungen Und Leistungen Veränderung Datum
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
Almirall EUR 258.05M 58.66M 2025-12
Avita Medical AUD 8.96M 1.69M 2025-12
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
IQVIA Holdings USD 3.75B 201M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Moderna USD 317M 50M 2025-12
Organon & Co USD 952M 122M 2025-12
Pharma Mar EUR 54.34M 10.54M 2025-12
Revvity USD 185.46M 9.66M 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
Viatris USD 1.33B 6.4M 2025-09
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12